首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1542632

全球生物製藥輔料市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Biopharmaceutical Excipients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 131 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球生物製藥輔料市場需求預計將從 2023 年的 31.2 億美元達到近 53.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.12%。

生物製藥輔料是配製生物製藥產品（如疫苗、單株抗體和基因療法）的惰性物質。它們具有多種功能，包括穩定活性成分、增強溶解度和改善藥物傳輸。這些賦形劑可包括穩定劑、防腐劑和增溶劑等物質，對於確保生物製藥的功效、安全性和品質至關重要。與傳統藥物中使用的賦形劑不同，它們必須滿足嚴格的監管要求和相容性標準，以確保它們不會干擾活性藥物成分 (API) 的生物活性。

市場動態

對生物製劑和先進療法的需求不斷成長，推動了生物製藥輔料市場的發展。隨著生物製藥產業的擴張，對專用賦形劑的需求不斷成長，以增強生物藥物的穩定性、遞送和功效。賦形劑在配製複雜的生物製劑（例如單株抗體和基因療法）中發揮著不可或缺的作用，這些生物製劑需要客製化的賦形劑解決方案來維持產品品質和性能。輔料開發的技術進步正在市場中創造重大機會。新型穩定劑和先進的輸送系統等賦形劑技術的創新正在改善生物製藥產品的配方和製造。這些進步使得開發更有效、更安全的治療方法成為可能，從而推動了對尖端輔料的需求。

對個人化醫療的日益關注也有助於生物製藥輔料市場的成長。個人化治療通常需要專門的賦形劑來解決獨特的配方挑戰並最佳化藥物傳遞。這一趨勢正在推動客製化輔料解決方案的開發，以支持不斷發展的個人化醫療領域。監管的進步和對品質控制的日益重視進一步推動了生物製藥輔料市場的發展。隨著監管機構對生物製藥生產實施更嚴格的指導方針，人們更加關注輔料的品質和合規性。這導致了對符合嚴格監管標準並確保產品安全性和有效性的輔料開發的投資增加。然而，高昂的研發成本和嚴格的監管要求可能會抑制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球生物製藥輔料市場的各個細分市場進行了包容性評估。生物製藥輔料產業的成長和趨勢為本研究提供了整體方法。

市場區隔

生物製藥輔料市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

增溶劑及界面活性劑/乳化劑（三酸甘油酯、酯類、其他）
多元醇（甘露醇、山梨醇、其他）
碳水化合物（蔗糖、葡萄糖、澱粉、其他）

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲生物製藥輔料市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。生物製藥輔料市場的主要參與者包括默克公司、卡樂康、巴斯夫公司、英國聯合食品公司、Signet Excipients Pvt.。 Ltd (IMCD)、Sigachi Industries Limited、Spectrum Chemical Manufacturing Corp.、Roquette FreRes、IMCD、科萊恩、DFE Pharma、J. Rettenmaier & SoHne GmbH + Co KG、Evonik Industries AG。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 7 章：生物製藥輔料公司的競爭格局

生物製藥輔料市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 8 章：公司簡介

頂級公司市佔率分析
市場集中度
Merck KGaA

公司概況
公司收入
產品
最新動態

Colorcon

公司概況
公司收入
產品
最新動態

BASF SE

公司概況
公司收入
產品
最新動態

Associated British Foods Plc

公司概況
公司收入
產品
最新動態

Signet Excipients Pvt. Ltd (IMCD)

公司概況
公司收入
產品
最新動態

Sigachi Industries Limited

公司概況
公司收入
產品
最新動態

Spectrum Chemical Manufacturing Corp.

公司概況
公司收入
產品
最新動態

Roquette FreRes

公司概況
公司收入
產品
最新動態

IMCD

公司概況
公司收入
產品
最新動態

Clariant

公司概況
公司收入
產品
最新動態

DFE Pharma

公司概況
公司收入
產品
最新動態

J. Rettenmaier & SoHne GmbH + Co KG

公司概況
公司收入
產品
最新動態

Evonik Industries AG

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11210576

The global demand for Biopharmaceutical Excipients Market is presumed to reach the market size of nearly USD 5.32 Billion by 2032 from USD 3.12 Billion in 2023 with a CAGR of 6.12% under the study period 2024-2032.

Biopharmaceutical excipients are inert substances that formulate biopharmaceutical products, such as vaccines, monoclonal antibodies, and gene therapies. They serve various functions, including stabilizing active ingredients, enhancing solubility, and improving drug delivery. These excipients can include substances like stabilizers, preservatives, and solubilizers, and are crucial in ensuring the efficacy, safety, and quality of biopharmaceuticals. Unlike excipients used in traditional pharmaceuticals, they must meet stringent regulatory requirements and compatibility standards to ensure they do not interfere with the biological activity of the active pharmaceutical ingredients (APIs).

Market Dynamics

The increasing demand for biologics and advanced therapeutics drives the biopharmaceutical excipients market. As the biopharmaceutical sector expands, there is a growing need for specialized excipients to enhance biologic drugs' stability, delivery, and efficacy. Excipients play an integral role in formulating complex biologics, such as monoclonal antibodies & gene therapies, which require tailored excipient solutions to maintain product quality and performance. Technological advancements in excipient development are creating significant opportunities within the market. Innovations in excipient technologies, such as novel stabilizers and advanced delivery systems, are improving the formulation and manufacturing of biopharmaceutical products. These advancements enable the development of more effective and safer therapeutics, driving demand for cutting-edge excipients.

The increasing focus on personalized medicine also contributes to biopharmaceutical excipients market growth. Personalized therapeutics often require specialized excipients to address unique formulation challenges and optimize drug delivery. This trend is driving the development of customized excipient solutions to support the growing field of personalized medicine. Regulatory advancements and a growing emphasis on quality control further drive the biopharmaceutical excipients market. As regulatory agencies impose stricter guidelines for biopharmaceutical manufacturing, there is a heightened focus on excipient quality and compliance. This has led to increased investment in the development of excipients that meet rigorous regulatory standards and ensure product safety and efficacy. However, high research and development costs and stringent regulatory requirements may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biopharmaceutical Excipients. The growth and trends of Biopharmaceutical Excipients industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biopharmaceutical Excipients market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others)
Polyols (Mannitol, Sorbitol, Others)
Carbohydrates (Sucrose, Dextrose, Starch, Others)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biopharmaceutical Excipients market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biopharmaceutical Excipients market include Merck KGaA, Colorcon, BASF SE, Associated British Foods Plc, Signet Excipients Pvt. Ltd (IMCD), Sigachi Industries Limited, Spectrum Chemical Manufacturing Corp., Roquette FreRes, IMCD, Clariant, DFE Pharma, J. Rettenmaier & SoHne GmbH + Co KG, Evonik Industries AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOPHARMACEUTICAL EXCIPIENTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others) Historic and Forecast Sales By Regions
5.4. Polyols (Mannitol, Sorbitol, Others) Historic and Forecast Sales By Regions
5.5. Carbohydrates (Sucrose, Dextrose, Starch, Others) Historic and Forecast Sales By Regions

6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE BIOPHARMACEUTICAL EXCIPIENTS COMPANIES

7.1. Biopharmaceutical Excipients Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8. COMPANY PROFILES OF BIOPHARMACEUTICAL EXCIPIENTS INDUSTRY

8.1. Top Companies Market Share Analysis
8.2. Market Concentration Rate
8.3. Merck KGaA
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
8.4. Colorcon
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
8.5. BASF SE
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
8.6. Associated British Foods Plc
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments
8.7. Signet Excipients Pvt. Ltd (IMCD)
- 8.7.1 Company Overview
- 8.7.2 Company Revenue
- 8.7.3 Products
- 8.7.4 Recent Developments
8.8. Sigachi Industries Limited
- 8.8.1 Company Overview
- 8.8.2 Company Revenue
- 8.8.3 Products
- 8.8.4 Recent Developments
8.9. Spectrum Chemical Manufacturing Corp.
- 8.9.1 Company Overview
- 8.9.2 Company Revenue
- 8.9.3 Products
- 8.9.4 Recent Developments
8.10. Roquette FreRes
- 8.10.1 Company Overview
- 8.10.2 Company Revenue
- 8.10.3 Products
- 8.10.4 Recent Developments
8.11. IMCD
- 8.11.1 Company Overview
- 8.11.2 Company Revenue
- 8.11.3 Products
- 8.11.4 Recent Developments
8.12. Clariant
- 8.12.1 Company Overview
- 8.12.2 Company Revenue
- 8.12.3 Products
- 8.12.4 Recent Developments
8.13. DFE Pharma
- 8.13.1 Company Overview
- 8.13.2 Company Revenue
- 8.13.3 Products
- 8.13.4 Recent Developments
8.14. J. Rettenmaier & SoHne GmbH + Co KG
- 8.14.1 Company Overview
- 8.14.2 Company Revenue
- 8.14.3 Products
- 8.14.4 Recent Developments
8.15. Evonik Industries AG
- 8.15.1 Company Overview
- 8.15.2 Company Revenue
- 8.15.3 Products
- 8.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (Tons and USD MN)
Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others) Market Sales By Geography (Tons and USD MN)
Polyols (Mannitol, Sorbitol, Others) Market Sales By Geography (Tons and USD MN)
Carbohydrates (Sucrose, Dextrose, Starch, Others) Market Sales By Geography (Tons and USD MN)
Global Biopharmaceutical Excipients Market Sales By Geography (Tons and USD MN)
North America Market Analysis (Tons and USD MN)
United States Market Analysis (Tons and USD MN)
Canada Market Analysis (Tons and USD MN)
Mexico Market Analysis (Tons and USD MN)
Europe Market Analysis (Tons and USD MN)
Europe Market Estimate By Country (Tons and USD MN)
United Kingdom Market Analysis (Tons and USD MN)
France Market Analysis (Tons and USD MN)
Germany Market Analysis (Tons and USD MN)
Italy Market Analysis (Tons and USD MN)
Russia Market Analysis (Tons and USD MN)
Spain Market Analysis (Tons and USD MN)
Rest of Europe Market Analysis (Tons and USD MN)
Asia Pacific Market Analysis (Tons and USD MN)
China Market Analysis (Tons and USD MN)
Japan Market Analysis (Tons and USD MN)
India Market Analysis (Tons and USD MN)
South Korea Market Analysis (Tons and USD MN)
Australia Market Analysis (Tons and USD MN)
South East Asia Market Analysis (Tons and USD MN)
Rest of Asia Pacific Market Analysis (Tons and USD MN)
Latin America Market Analysis (Tons and USD MN)
Brazil Market Analysis (Tons and USD MN)
Argentina Market Analysis (Tons and USD MN)
Peru Market Analysis (Tons and USD MN)
Chile Market Analysis (Tons and USD MN)
Rest of Latin America Market Analysis (Tons and USD MN)
Middle East & Africa Market Analysis (Tons and USD MN)
Saudi Arabia Market Analysis (Tons and USD MN)
UAE Market Analysis (Tons and USD MN)
Israel Market Analysis (Tons and USD MN)
South Africa Market Analysis (Tons and USD MN)
Rest of Middle East and Africa Market Analysis (Tons and USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Biopharmaceutical Excipients Report
Market Research Process
Market Research Methodology
Global Biopharmaceutical Excipients Market Size, By Region (Tons and USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (Tons and USD MN)
Solubilizes & Surfactants/Emulsifiers (Triglycerides, Esters, Others) Market Sales By Geography (Tons and USD MN)
Polyols (Mannitol, Sorbitol, Others) Market Sales By Geography (Tons and USD MN)
Carbohydrates (Sucrose, Dextrose, Starch, Others) Market Sales By Geography (Tons and USD MN)
Global Market Sales (Tons and USD MN)
North America Market Sales (Tons and USD MN)
Europe Market Sales (Tons and USD MN)
Asia Pacific Market Sales (Tons and USD MN)
Latin America Market Sales (Tons and USD MN)
Middle East & Africa Market Sales (Tons and USD MN)
Recent Development in Industry
Top Company Market Share Analysis